• American family physician · Aug 2021

    SGLT2 Inhibitors or GLP-1 Receptor Agonists Reduce Cardiovascular Outcomes in Patients with Type 2 Diabetes.

    • Allen F Shaughnessy.
    • Tufts University, Boston, MA, USA.
    • Am Fam Physician. 2021 Aug 1; 104 (2): 206206.

    no abstract available

      Pubmed     Free full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.